Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 12:00 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1897–1920 of 3,077 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Intracranial Vascular Disorders Clear all

Conditions: Brain Aneurysm
Interventions: Not listed
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Carotid Stenosis
Interventions: CorMatrix ECM for Carotid Repair; Device
Lead sponsor: Elutia Inc.; Industry
Eligibility: Not listed
Enrollment: 230 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 6
States / cities: Birmingham, Alabama • Marietta, Georgia • Indianapolis, Indiana + 3 more

Conditions: Dementia, Dementia, Vascular, Dementia With Lewy Bodies, Dementia Frontal, Dementia, Mixed, Dementia Alzheimers, Alzheimer Disease, Dementia Severe
Interventions: ADRD-PC Program; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 55 Years and older
Enrollment: 884 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 5
States / cities: Denver, Colorado • Atlanta, Georgia • Indianapolis, Indiana + 2 more

Conditions: Cerebrovascular Disorder, Healthy, Movement Disorder, Nervous System Disease, Spinal Cord Injury
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: Not listed
Enrollment: 610 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1992 – 2002
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Sickle Cell Anemia, Stroke
Interventions: transfusion therapy; Procedure
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 5 Years to 14 Years
Enrollment: 196 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2013
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Acute Stroke
Interventions: SCM, SCM and VSSP; Other
Lead sponsor: Michigan State University; Other
Eligibility: 18 Years and older
Enrollment: 320 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 3
States / cities: Ann Arbor, Michigan • Lansing, Michigan • Ypsilanti, Michigan

Conditions: Carotid Artery Stenosis
Interventions: CAS with cerebral protection, CAS without cerebral protection; Device
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 52 participants
Timeline: 2003 – 2007
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Aphasia, Stroke
Interventions: ORLA, ORLA + Writing; Behavioral
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 18 Years to 80 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Subacute Stroke, Acute Stroke
Interventions: MindPod Dolphin VGT, Bimanual Arm Trainer VGT; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 21 Years to 90 Years
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Cerebrovascular Accident
Interventions: Transcranial magnetic stimulation (TMS); Procedure
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: Not listed
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2005
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Stroke, Upper Extremity Paresis, Hemiplegia
Interventions: Active conventional tDCS montage plus CCFES, Active unconventional tDCS montage plus CCFES, Sham tDCS plus CCFES, CCFES with Occupational Therapy; Device · Behavioral
Lead sponsor: MetroHealth Medical Center; Other
Eligibility: 21 Years to 90 Years
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Stroke, Chronic Stroke, Intracerebral Haemorrhage, Intracerebral Haemorrhage (ICH), Intracerebral Hemorrhage Basal Ganglia, Ischemic Stroke, Ischemic Stroke and Hemorrhagic Stroke, Hemiparesis After Stroke, Hemiplegia Following Ischemic Stroke, Hemiplegia and Hemiparesis, Hemiplegia and/or Hemiparesis Following Stroke, Middle Cerebral Artery Stroke
Interventions: Psilocybin (Usona Institute); Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Intracerebral Hemorrhage, Ischemic Stroke, Spironolactone
Interventions: Spironolactone Pill; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 5
States / cities: New Haven, Connecticut • Winston-Salem, North Carolina • Philadelphia, Pennsylvania + 1 more

Conditions: Acute Ischemic Stroke
Interventions: J147 Emulsion for Injection, Placebo; Drug · Other
Lead sponsor: Abrexa Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 196 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 5
States / cities: Long Beach, California • Rockford, Illinois • Albany, New York + 2 more

Conditions: Cardiac Arrythmias, Syncope, Atrial Fibrillation, Atrial Flutter, Tachycardia, Stroke
Interventions: Abbott, Inc Confirm Rx™ versus Medtronic, Inc Reveal LINQTM; Device
Lead sponsor: Sparrow Clinical Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 209 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 2
States / cities: Lansing, Michigan • Traverse City, Michigan

Conditions: Carotid Stenosis, Caloric Restriction
Interventions: ScandiShake; Dietary Supplement
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Stroke
Interventions: Standard Occupational Therapy Arm Exercise Program; Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 80 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Stroke, Hemiparesis
Interventions: Active rTMS, Sham rTMS, Open Placebo; Device · Dietary Supplement
Lead sponsor: Spaulding Rehabilitation Hospital; Other
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Acute Ischemic Stroke
Interventions: DP-b99, Placebo; Drug
Lead sponsor: D-Pharm Ltd.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 446 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 13
States / cities: Oceanside, California • Danbury, Connecticut • Savannah, Georgia + 10 more

Conditions: Stroke
Interventions: No Exoskeleton, Exoskeleton (zero impedance), Exoskeleton (low impedance), Exoskeleton (medium impedance), Exoskeleton (high impedance); Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 21 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Hypoxic Ischemic Brain Injury, Neonatal Encephalopathy
Interventions: Near-Infrared Spectroscopy (NIRS); Device
Lead sponsor: Boston Children's Hospital; Other
Eligibility: Up to 2 Years
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2028
U.S. locations: 3
States / cities: Boston, Massachusetts

Conditions: Stroke, Acute
Interventions: hypothermia and anti-shivering treatment, Group1: IV t-PA and normothermia; Device · Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 22 Years to 82 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 29
States / cities: Birmingham, Alabama • Los Angeles, California • Newport Beach, California + 25 more

Conditions: Stroke
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 80 Years
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2013
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Acute Ischemic Stroke
Interventions: Intravenous glenzocimab (ACT017) 1000 mg, Intravenous Placebo; Drug
Lead sponsor: Acticor Biotech; Industry
Eligibility: 18 Years and older
Enrollment: 438 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 9
States / cities: Bradenton, Florida • St. Petersburg, Florida • Chicago, Illinois + 4 more

Search by objective public record fields.

Aneurysm Genetic Risk in Patients With QIB Changes

CorMatrix ECM for Carotid Repair Following Endarterectomy Registry

Palliative Care for Persons With Late-stage Alzheimer's and Related Dementias and Their Caregivers

Magnetic Resonance Imaging Studies of Motor and Thought Processes

Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial

Michigan Stroke Transitions Trial

A Randomized Trial of Carotid Artery Stenting With and Without Cerebral Protection

Enhancing Written Communication in Persons With Aphasia

Feasibility of Video Gaming Technology for Arm Recovery Early Post-stroke

Enhancement of Use-Dependent Plasticity by Somatosensory Stimulation in Chronic Stroke

tDCS + CCFES-mediated Functional Task Practice for Post-stroke Upper Extremity Hemiplegia

Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability

Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke

Safety and Efficacy of J147 in Acute Ischemic Stroke

Confirm Rx™ Versus Reveal LINQ™ - Which is More Reliable in Data Transmission? A Randomized Clinical Study

Short-Term Endogenous Hydrogen Sulfide Upregulation

CompARing Long terM Outcomes in Chronic Stroke Survivors Across Investigational Assessments Following a Prescribed Upper Extremity Exercise Program

Mechanisms of Open and Hidden Placebo in Stroke Recovery

Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke

Exoskeleton for Balance

Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia

The Intravascular Cooling in the Treatment of Stroke 2/3 Trial

Moving a Paralyzed Hand Through Use of a Brain-Computer Interface

ACTISAVE: ACuTe Ischemic Stroke Study Evaluating Glenzocimab Used as Add-on Therapy Versus placEbo